Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedFooter updated: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedPublications section now states that items are automatically filled from PubMed, and a UI revision note shows Revision: v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe government funding notice banner was removed from the page, a general operational alert that did not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check66 days agoChange DetectedNo significant changes to the study details are evident between the old and new screenshots; the page content and structure remain the same aside from minor UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check95 days agoChange DetectedVersion updated from v3.1.0 to v3.2.0 and an operational-status notice added; no other core content or pricing changes detected.SummaryDifference7%

- Check102 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.